"Hepatocellular carcinoma HCC" trang 1 - tải miễn phí từ tailieuXANH
Hepatocellular carcinoma (HCC): A global perspective

Hepatocellular carcinoma (HCC): A global perspective
14    55    0
Synthesis of novel SN38-aspirin prodrugs for the treatment of hepatocellular carcinoma

Synthesis of novel SN38-aspirin prodrugs for the treatment of hepatocellular carcinoma
11    185    1
Cholesterol-conjugated let-7a mimics: Antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy

Cholesterol-conjugated let-7a mimics: Antitumor efficacy on hepatocellular carcinoma in vitro and in a preclinical orthotopic xenograft model of systemic therapy
13    50    0
Systemic therapy for hepatocellular carcinoma: A reviewa

Systemic therapy for hepatocellular carcinoma: A reviewa
6    81    0
Constructing a molecular genotyping assay for rs11077 based on real-time polymerase chain reaction high resolution melting (PCR HRM) technique for the prognosis of hepatocellular carcinoma (HCC) patients

Constructing a molecular genotyping assay for rs11077 based on real-time polymerase chain reaction high resolution melting (PCR HRM) technique for the prognosis of hepatocellular carcinoma (HCC) patients
7    105    1
Synergistic antitumor effect of sorafenib in combination with ATM inhibitor in hepatocellular carcinoma cells

Synergistic antitumor effect of sorafenib in combination with ATM inhibitor in hepatocellular carcinoma cells
7    45    0
Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NFκB signaling pathway

Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NFκB signaling pathway
14    276    0
Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma

Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma
11    49    0
Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): A study protocol

Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): A study protocol
7    88    0
CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
10    51    0
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): Study protocol for a prospective randomized trial

Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): Study protocol for a prospective randomized trial
8    55    0
Incarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition

Incarvine C suppresses proliferation and vasculogenic mimicry of hepatocellular carcinoma cells via targeting ROCK inhibition
12    65    0
Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)

Transarterial injection of recombinant human type-5 adenovirus H101 in combination with transarterial chemoembolization (TACE) improves overall and progressive-free survival in unresectable hepatocellular carcinoma (HCC)
9    58    0
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)

Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
8    65    0
MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3

MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3
9    62    0
Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients
9    30    1
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma

PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma
10    37    1
Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNASeq datasets and machine learning

Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNASeq datasets and machine learning
15    229    1
Association of ISG20 rs4566136 polymorphism with hepatitis B virus related hepatocellular carcinoma

Association of ISG20 rs4566136 polymorphism with hepatitis B virus related hepatocellular carcinoma
10    22    1
Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients

Special role of Foxp3 for the specifically altered microRNAs in Regulatory T cells of HCC patients
10    74    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.